131 related articles for article (PubMed ID: 30868891)
21. Differential expression profiling of circulation microRNAs in PTC patients with non-131I and 131I-avid lungs metastases: a pilot study.
Qiu ZL; Shen CT; Song HJ; Wei WJ; Luo QY
Nucl Med Biol; 2015 May; 42(5):499-504. PubMed ID: 25682061
[TBL] [Abstract][Full Text] [Related]
22. miR-219-5p modulates cell growth of papillary thyroid carcinoma by targeting estrogen receptor α.
Huang C; Cai Z; Huang M; Mao C; Zhang Q; Lin Y; Zhang X; Tang B; Chen Y; Wang X; Qian Z; Ye L; Peng Y; Xu H
J Clin Endocrinol Metab; 2015 Feb; 100(2):E204-13. PubMed ID: 25423566
[TBL] [Abstract][Full Text] [Related]
23. MiR-758-3p regulates papillary thyroid cancer cell proliferation and migration by targeting TAB1.
Chen J; Xu Z; Yu C; Wu Z; Yin Z; Fang F; Chen B
Pharmazie; 2019 Apr; 74(4):235-238. PubMed ID: 30940308
[TBL] [Abstract][Full Text] [Related]
24. Decreased serum exosomal miR-29a expression and its clinical significance in papillary thyroid carcinoma.
Wen Q; Wang Y; Li X; Jin X; Wang G
J Clin Lab Anal; 2021 Jan; 35(1):e23560. PubMed ID: 33368640
[TBL] [Abstract][Full Text] [Related]
25. Role of Lin28A/let-7a/c-Myc Pathway in Growth and Malignant Behavior of Papillary Thyroid Carcinoma.
Huang J; Lin H; Zhong M; Huang J; Sun S; Lin L; Chen Y
Med Sci Monit; 2018 Dec; 24():8899-8909. PubMed ID: 30531691
[TBL] [Abstract][Full Text] [Related]
26. miR-335-5p targeting ICAM-1 inhibits invasion and metastasis of thyroid cancer cells.
Luo L; Xia L; Zha B; Zuo C; Deng D; Chen M; Hu L; He Y; Dai F; Wu J; Wang C; Wang Y; Zhang Q
Biomed Pharmacother; 2018 Oct; 106():983-990. PubMed ID: 30119270
[TBL] [Abstract][Full Text] [Related]
27. Proteomics study of serum exosomes from papillary thyroid cancer patients.
Luo D; Zhan S; Xia W; Huang L; Ge W; Wang T
Endocr Relat Cancer; 2018 Oct; 25(10):879-891. PubMed ID: 29895528
[TBL] [Abstract][Full Text] [Related]
28. Long noncoding RNA LINC00313 modulates papillary thyroid cancer tumorigenesis via sponging miR-4429.
Wu WJ; Yin H; Hu JJ; Wei XZ
Neoplasma; 2018 Nov; 65(6):933-942. PubMed ID: 29940766
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-based molecular classification of papillary thyroid carcinoma.
Rosignolo F; Memeo L; Monzani F; Colarossi C; Pecce V; Verrienti A; Durante C; Grani G; Lamartina L; Forte S; Martinetti D; Giuffrida D; Russo D; Basolo F; Filetti S; Sponziello M
Int J Oncol; 2017 May; 50(5):1767-1777. PubMed ID: 28393181
[TBL] [Abstract][Full Text] [Related]
30. Family of microRNA-146 Regulates RARβ in Papillary Thyroid Carcinoma.
Czajka AA; Wójcicka A; Kubiak A; Kotlarek M; Bakuła-Zalewska E; Koperski Ł; Wiechno W; Jażdżewski K
PLoS One; 2016; 11(3):e0151968. PubMed ID: 27011326
[TBL] [Abstract][Full Text] [Related]
31. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.
Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X
Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928
[TBL] [Abstract][Full Text] [Related]
32. miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4.
Wei C; Song H; Sun X; Li D; Song J; Hua K; Fang L
Oncol Rep; 2015 Jul; 34(1):211-20. PubMed ID: 26063221
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer.
Geraldo MV; Yamashita AS; Kimura ET
Oncogene; 2012 Apr; 31(15):1910-22. PubMed ID: 21874046
[TBL] [Abstract][Full Text] [Related]
34. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
[TBL] [Abstract][Full Text] [Related]
35. MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2.
Xue KC; Hu DD; Zhao L; Li N; Shen HY
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3794-3800. PubMed ID: 28975989
[TBL] [Abstract][Full Text] [Related]
36. Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma.
Liu F; Yin R; Chen X; Chen W; Qian Y; Zhao Y; Jiang Y; Ma D; Hu T; Yu T; Zhu Y; Zhang Y
Biomed Pharmacother; 2019 Jun; 114():108605. PubMed ID: 30904818
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer.
Geraldo MV; Nakaya HI; Kimura ET
Oncotarget; 2017 Feb; 8(6):9597-9607. PubMed ID: 28030816
[TBL] [Abstract][Full Text] [Related]
38. LncRNA BISPR promotes the progression of thyroid papillary carcinoma by regulating miR-21-5p.
Zhang H; Cai Y; Zheng L; Zhang Z; Lin X; Jiang N
Int J Immunopathol Pharmacol; 2018; 32():2058738418772652. PubMed ID: 29856242
[TBL] [Abstract][Full Text] [Related]
39. Plasma exosomal miR-21 and miR-181a differentiates follicular from papillary thyroid cancer.
Samsonov R; Burdakov V; Shtam T; Radzhabovа Z; Vasilyev D; Tsyrlina E; Titov S; Ivanov M; Berstein L; Filatov M; Kolesnikov N; Gil-Henn H; Malek A
Tumour Biol; 2016 Sep; 37(9):12011-12021. PubMed ID: 27164936
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-146b: A Novel Biomarker and Therapeutic Target for Human Papillary Thyroid Cancer.
Chou CK; Liu RT; Kang HY
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28294980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
